Comparative analysis of the use and control of thalidomide in Brazil and different countries: is it possible to say there is safety?-Reference-Cited by-同舟云学术

Comparative analysis of the use and control of thalidomide in Brazil and different countries: is it possible to say there is safety?

Published:2021-07-15 Issue:1 Volume:21 Page:67-81
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

de Jesus Soraya Machado¹^ORCID,Santana Rafael Santos²^ORCID,Leite Silvana Nair³^ORCID

Affiliation:

1. Postgraduate Program in Pharmaceutical Sciences, University of Brasília, Brasília, Distrito Federal, Brazil

2. Department of Pharmacy, University of Brasília, Brasília, Distrito Federal, Brazil

3. Department of Pharmaceutical Sciences, Federal University of Santa Catarina, Florianópolis, Santa Catarina, Brazil

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2021.1953467

Reference142 articles.

1. The Return of Thalidomide

2. Talidomida no Brasil: vigilância com responsabilidade compartilhada?

3. Talidomida: una historia inacabada

4. Thalidomide‐induced teratogenesis: History and mechanisms

5. Moro A. Participação Social e Regulação de Medicamentos: o Caso da Talidomida no Brasil. [Social Participation and Drug Regulation: the Case of Thalidomide in Brazil] [dissertation]. Curitiba (PR): Federal University of Paraná. 2017. Portuguese.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioinformatic Approach for Repurposing Immunomodulatory Drugs for Lepromatous Leprosy;The International Journal of Mycobacteriology;2023-10

2. Thalidomide: history, withdrawal, renaissance, and safety concerns;Expert Opinion on Drug Safety;2021-11-02